Skip to main navigation Skip to search Skip to main content

Serum copper, ceruloplasmin and thiobarbituric acid reactive substance status in patients with ovarian cancer

Research output: Contribution to journalArticlepeer-review

Abstract

Serum copper, ceruloplasmin and thiobarbituric acid reactive substances (TBARS) were estimated in 30 patients of ovarian cancer. The copper to ceruloplasmin ratio was moderately increased (P<0.05) but the copper (P<0.01) and ceruloplasmin (P<0.001) levels were significantly increased in ovarian cancer patients as compared to controls. TBARS levels were also found to be highly significant (P<0.001). Trace elements and free radicals have been implicated in the etiology of cancer. Hence the estimation of antioxidants like ceruloplasmin and TBARS along with the trace element like copper may be of value in the early diagnosis of cancer.

Original languageEnglish
Pages (from-to)486-488
Number of pages3
JournalIndian Journal of Physiology and Pharmacology
Volume48
Issue number4
Publication statusPublished - 10-2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology
  • Physiology (medical)

Fingerprint

Dive into the research topics of 'Serum copper, ceruloplasmin and thiobarbituric acid reactive substance status in patients with ovarian cancer'. Together they form a unique fingerprint.

Cite this